Response to 'Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin'.
Br J Dermatol
; 187(2): 275, 2022 08.
Article
in En
| MEDLINE
| ID: mdl-35261023
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Diseases
/
Immunoconjugates
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Br J Dermatol
Year:
2022
Document type:
Article
Affiliation country:
Japan
Country of publication:
United kingdom